The intronic variant rs3115534-G was by far the most frequently observed in AAC, AFR, and CAH, as previously reported.17 These findings emphasize the importance of GBA1 as a globally relevant therapeutic target, an important observation given that most trials targeting glucocerebrosidase only include EUR or AJ individuals.4 Here, GBA1 is linked to congenital adrenal hyperplasia.